Hepatocyte-specific deletion of hepatocyte nuclear factor-4αin adult mice results in increased hepatocyte proliferation

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 304, Issue 1, 2013, Pages

  Walesky, Chad ^a   Gunewardena, Sumedha ^a   Terwilliger, Ernest F ^b   Edwards, Genea ^a   Borude, Prachi ^a   Apte, Udayan ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 4ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DOWN REGULATION; GENE DELETION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; IMMUNOHISTOCHEMISTRY; LIVER CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CAPILLARY ELECTROCHROMATOGRAPHY; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DEPENDOVIRUS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE DELETION; HEPATOCYTE NUCLEAR FACTOR 4; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; LIVER REGENERATION; MICE; MICE, KNOCKOUT; MICROARRAY ANALYSIS; MITOSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84871876340     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00064.2012     Document Type: Article

References (38)

1. Apte U, Gkretsi V, Bowen WC, Mars WM, Luo JH, Donthamsetty S, Orr A, Monga SP, Wu C, Michalopoulos GK. Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology 50: 844-851, 2009.
2. Battle MA, Konopka G, Parviz F, Gaggl AL, Yang C, Sladek FM, Duncan SA. Hepatocyte nuclear factor 4α orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci USA 103: 8419-8424, 2006.
3. Bolotin E, Liao H, Ta TC, Yang C, Hwang-Verslues W, Evans JR, Jiang T, Sladek FM. Integrated approach for the identification of human hepatocyte nuclear factor 4α target genes using protein binding microarrays. Hepatology 51: 642-653, 2010.
4. Bonzo JA, Ferry CH, Matsubara T, Kim JH, Gonzalez FJ. Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4α in adult mice. J Biol Chem 287: 7345-7356, 2012.
5. Bonzo JA, Ferry CH, Matsubara T, Kim JH, Gonzalez FJ. Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4α in adult mice. J Biol Chem 287: 7345-7356, 2012.
6. Bryne JC, Valen E, Tang MH, Marstrand T, Winther O, da Piedade I, Krogh A, Lenhard B, Sandelin A. JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update. Nucleic Acids Res 36: D102-D106, 2008.
7. Buchholz DR, Bindu D, Shi YB. Chromatin immunoprecipitation for in vivo studies of transcriptional regulation during development. In: Analysis of Growth Factor Signaling in Embryos, edited by Whitman M, Sater A. Boca Raton, FL: CRC, 2007, p. 305-319.
8. Erdmann S, Senkel S, Arndt T, Lucas B, Lausen J, Klein-Hitpass L, Ryffel GU, Thomas H. Tissue-specific transcription factor HNF4α inhibits cell proliferation and induces apoptosis in the pancreatic INS-1 betacell line. Biol Chem 388: 91-106, 2007.
9. Flodby P, Liao DZ, Blanck A, Xanthopoulos KG, Hallstrom IP. Expression of the liver-enriched transcription factors C/EBPα, C/EBPβ, HNF-1, and HNF-4 in preneoplastic nodules and hepatocellular carcinoma in rat liver. Mol Carcinog 12: 103-109, 1995.
10. Garrison WD, Battle MA, Yang C, Kaestner KH, Sladek FM, Duncan SA. Hepatocyte nuclear factor 4α is essential for embryonic development of the mouse colon. Gastroenterology 130: 1207-1220, 2006.
11. Gonzalez FJ. Regulation of hepatocyte nuclear factor 4α-mediated transcription. Drug Metab Pharmacokinet 23: 2-7, 2008.
12. Grigo K, Wirsing A, Lucas B, Klein-Hitpass L, Ryffel GU. HNF4α orchestrates a set of 14 genes to down-regulate cell proliferation in kidney cells. Biol Chem 389: 179-187, 2008.
13. Hastie ND, Held WA, Toole JJ. Multiple genes coding for the androgen-regulated major urinary proteins of the mouse. Cell 17: 449-457, 1979.
14. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, Ogata H, Karin M, Struhl K, Hadzopoulou-Cladaras M, Iliopoulos D. An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 147: 1233-1247, 2011.
15. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. Hepato-cyte nuclear factor 4α (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 21: 1393-1403, 2001.
16. Ho KJ, Bass CE, Kroemer AH, Ma C, Terwilliger E, Karp SJ. Optimized adeno-associated virus 8 produces hepatocyte-specific Cre-mediated recombination without toxicity or affecting liver regeneration. Am J Physiol Gastrointest Liver Physiol 295: G412-G419, 2008.
17. Hoffman BG, Robertson G, Zavaglia B, Beach M, Cullum R, Lee S, Soukhatcheva G, Li L, Wederell ED, Thiessen N, Bilenky M, Cezard T, Tam A, Kamoh B, Birol I, Dai D, Zhao Y, Hirst M, Verchere CB, Helgason CD, Marra MA, Jones SJ, Hoodless PA. Locus co-occupancy, nucleosome positioning, and H3K4me1 regulate the functionality of FOXA2-, HNF4A-, and PDX1-bound loci in islets and liver. Genome Res 20: 1037-1051, 2010.
18. Inoue Y, Hayhurst GP, Inoue J, Mori M, Gonzalez FJ. Defective ureagenesis in mice carrying a liver-specific disruption of hepatocyte nuclear factor 4α (HNF4α). HNF4α regulates ornithine transcarbamylase in vivo. J Biol Chem 277: 25257-25265, 2002.
19. Inoue Y, Peters LL, Yim SH, Inoue J, Gonzalez FJ. Role of hepatocyte nuclear factor 4α in control of blood coagulation factor gene expression. JMol Med 84: 334-344, 2006.
20. Inoue Y, Yu AM, Inoue J, Gonzalez FJ. Hepatocyte nuclear factor 4α is a central regulator of bile acid conjugation. J Biol Chem 279: 2480-2489, 2004.
21. Inoue Y, Yu AM, Yim SH, Ma X, Krausz KW, Inoue J, Xiang CC, Brownstein MJ, Eggertsen G, Bjorkhem I, Gonzalez FJ. Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4α. J Lipid Res 47: 215-227, 2006.
22. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15, 2003.
23. Kalkuhl A, Kaestner K, Buchmann A, Schwarz M. Expression of hepatocyte-enriched nuclear transcription factors in mouse liver tumours. Carcinogenesis 17: 609-612, 1996.
24. Kato T, Sato N, Hayama S, Yamabuki T, Ito T, Miyamoto M, Kondo S, Nakamura Y, Daigo Y. Activation of Holliday junction recognizing protein involved in the chromosomal stability and immortality of cancer cells. Cancer Res 67: 8544-8553, 2007.
25. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25, 2009.
26. Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, Morozova OV, Fleishman DI, Engelhardt NV, Duncan SA. Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology 39: 10381047, 2004.
27. Michalopoulos GK. Liver regeneration. J Cell Physiol 213: 286-300, 2007.
28. Morin P, Flors C, Olson MF. Constitutively active RhoA inhibits proliferation by retarding G1 to S phase cell cycle progression and impairing cytokinesis. Eur J Cell Biol 88: 495-507, 2009.
29. Ning BF, Ding J, Yin C, Zhong W, Wu K, Zeng X, Yang W, Chen YX, Zhang JP, Zhang X, Wang HY, Xie WF. Hepatocyte nuclear factor 4α suppresses the development of hepatocellular carcinoma. Cancer Res 70: 7640-7651, 2010.
30. Ong CK, Ng CY, Leong C, Ng CP, Foo KT, Tan PH, Huynh H. Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis. J Biol Chem 279: 743-754, 2004.
31. Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, Ning G, Kaestner KH, Rossi JM, Zaret KS, Duncan SA. Hepatocyte nuclear factor 4α controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 34: 292-296, 2003.
32. Pineda Torra I, Jamshidi Y, Flavell DM, Fruchart JC, Staels B. Characterization of the human PPARa promoter: identification of a functional nuclear receptor response element. Mol Endocrinol 16: 1013-1028, 2002.
33. Salmon-Divon M, Dvinge H, Tammoja K, Bertone P. PeakAnalyzer: genome-wide annotation of chromatin binding and modification loci. BMC Bioinformatics 11: 415, 2010.
34. Ungaro P, Teperino R, Mirra P, Longo M, Ciccarelli M, Raciti GA, Nigro C, Miele C, Formisano P, Beguinot F. Hepatocyte nuclear factor (HNF)-4α-driven epigenetic silencing of the human PED gene. Diabeto-logia 53: 1482-1492, 2010.
35. Weissglas-Volkov D, Huertas-Vazquez A, Suviolahti E, Lee J, Plaisier C, Canizales-Quinteros S, Tusie-Luna T, Aguilar-Salinas C, Taskinen MR, Pajukanta P. Common hepatic nuclear factor-4α variants are associated with high serum lipid levels and the metabolic syndrome. Diabetes 55: 1970-1977, 2006.
36. Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, Ji Y, Wu X, Han Z, Hu G. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res 61: 3176-3181, 2001.
37. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 384: 458-460, 1996.
38. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, Liu XS. Model-based analysis of ChIP-Seq (MACS). Genome Biol 9: R137, 2008.